alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 31.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                      AS ADOPTED PURSUANT TO SECTION 302 OF
                         THE SARBANES-OXLEY ACT OF 2002

I, L. B. (Brad) Clarke, certify that:

1.   I have reviewed this quarterly report for the period ending March 31, 2005
on Form 10-QSB of Organetix, Inc.;

2.   Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3.   Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4.   I am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
registrant and have:

     a) designed such disclosure controls and procedures to ensure that material
     information relating to the registrant, including its consolidated
     subsidiaries, is made known to us by others within those entities,
     particularly during the period in which this quarterly report is being
     prepared;

     b) evaluated the effectiveness of the registrant's disclosure controls and
     procedures as of a date within 90 days prior to the filing date of this
     quarterly report (the "Evaluation Date"); and

     c) presented in this quarterly report my conclusions about the
     effectiveness of the disclosure controls and procedures based on our
     evaluation as of the Evaluation Date;

5.   I have disclosed, based on our most recent evaluation, to the registrant's
auditors and the audit committee of registrant's board of directors (or persons
performing the equivalent functions):

     a) all significant deficiencies in the design or operation of internal
     controls which could adversely affect the registrant's ability to record,
     process, summarize and report financial data and have identified for the
     registrant's auditors any material weaknesses in internal controls; and

     b) any fraud, whether or not material, that involves management or other
     employees who have a significant role in the registrant's internal
     controls; and

6.   I have indicated in this quarterly report whether or not there were
significant changes in internal controls or in other factors that could
significantly affect internal controls subsequent to the date of my most recent
evaluation, including any corrective actions with regard to significant
deficiencies and material weaknesses.


Date: May 10, 2005


/s/ L. B. (Brad) Clarke
------------------------------
Name: L. B. (Brad) Clarke
Title: Chief Executive Officer
Exhibit 23.1 

                        CONSENT OF INDEPENDENT AUDITORS

We consent to the incorporation by reference in the Registration Statement Form
S-3 (No. 333-36487) of Chelsea GCA Realty, Inc. and Chelsea GCA Realty
Partnership, L.P. and in the related Prospectus of our report dated February 10,
1999, with respect to the consolidated financial statements and schedule of
Chelsea GCA Realty Partnership, L.P. included in this Annual Report (Form 10-K)
for the year ended December 31, 1998.

                              Ernst & Young LLP


New York, New York
March 23, 1999
**Exhibit 32.2**

 

**CERTIFICATION**

**PURSUANT TO SECTION 906 OF THE SARBANES-OXLEYACT OF 2002**

**(SUBSECTIONS (A) AND (B) OF SECTION1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE)**

 

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002(subsections (a) and (b) of Section 1350, Chapter 63 ofTitle 18, United States Code), I, Darrell Borne, the Chief FinancialOfficer, Secretary and Treasurer of First Horizon Pharmaceutical Corporation, aDelaware corporation (the “Company”), do hereby certify, to the best of my knowledge,that:

 

This Quarterly Report on Form 10-Q for the quarter endedMarch 31, 2006 (the “Form 10-Q”) of the Company fully complies withthe requirements of Section 13(a) or 15(d) of the Securities Exchange Actof 1934 and the information contained in this Form 10-Q fairly presents,in all material respects, the financial condition and results of operations ofthe Company.

 
| April 27, 2006 | By:                                          | /s/ DARRELL BORNE |
|----------------|----------------------------------------------|-------------------|
|           | Name: Darrell Borne                          |
|           | Title: *Chief Financial Officer,  Secretary* |
|           | *and Treasurer*                         |

 

A signed original of this written statement required bySection 906, or other document authenticating, acknowledging or otherwiseadopting the signature that appears in typed form within the electronic versionof this written statement required by Section 906, has been provided toFirst Horizon Pharmaceutical Corporation and will be retained by First HorizonPharmaceutical Corporation and furnished to the Securities and ExchangeCommission or its staff upon request.

 

1

----
Exhibit 32.1





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002








The undersigned hereby certifies, in her capacity as Chief Executive Officer of China Pharma Holdings, Inc. (the “Company”), for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of her knowledge:





(1)  The Company’s Amendment No. 1 to Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2010 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.








Dated:  March 15, 2011





/s/ Zhilin Li


--------------------------------


Name: Zhilin Li


President and Chief Executive Officer


(principal executive officer)








This certification accompanies each Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.





A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
**EXHIBIT      32.1**

**CERTIFICATION      OF CHIEF FINANCIAL OFFICER**

**PURSUANT      TO 18 U.S.C. SECTION 1350,**

**AS      ADOPTED PURSUANT TO**

**SECTION      906 OF THE SARBANES-OXLEY ACT OF 2002**

| (1) | The                Report fully complies with the requirements of section 13(a) or 15(d)of                the Securities Exchange Act of 1934;                and |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | The                information contained in the Report fairly presents, in all material                respects, the financial condition and result of operations of the                Company. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                                                                                      | /s/                Doug D’Agata |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------|
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Doug                D’Agata     |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Authorized                Officer     |

----
Exhibit 32.1

CERTIFICATION  PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  (SUBSECTIONS (A) AND (B) OF SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE)

Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Patrick P. Fourteau, the
Chief Executive Officer and President of First Horizon Pharmaceutical Corporation, a Delaware corporation (the "Company"), do hereby certify, to the best of my knowledge, that:



|May 6, 2005 |  | By: |  | /s/PATRICK P. FOURTEAUName: Patrick P. Fourteau
Title:Chief Executive Officer and President
|----------- |  | --- |  | -------------------------------------------------------------------------------------------

A
signed original of this written statement required by Section 906, or other document authenticating, acknowledging or otherwise adopting the signature that appears in typed form within the
electronic version of this written statement required by Section 906, has been provided to First Horizon Pharmaceutical Corporation and will be retained by First Horizon Pharmaceutical
Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

---



QuickLinks
From: Melanie King/RTP/USEPA/US

To: parise.tanya@ecrweb.com

Date: Wednesday, February 17, 2010 05:08PM Subject: information on catalyst installation

Tanya, I talked to Jim McDonald with Miratech this af ternoon regarding installi ng catalysts on engines located in cold weather areas and on offshore pl atforms. He indicated that engines on offshore platforms are typically equipped wi th a silencer (possibly due to OSHA requirements). He said that the catalyst can be put in the silencer, so it would not take up any additional space on the platform. Regarding engines located in cold weather areas, he indicated that there were no issues with installing an oxidation catalyst in a cold weather location. If the engine is enclosed to protect it from the cold, the catalyst can be installed on the roof of the en closure. He did not indicate that the cost would be significantly higher to install a catalyst in a cold weather location.

Melanie King Energy Strategies Group Sector Policies and Programs Division Office of Air Quality Planning and Standards U.S. Environmental Protection Agency

Mail Code D243-01 RTP, NC 27711

Phone: (919) 541-2469 Fax: (919) 541-5450 king.melanie@epa.gov 

### Pa g e 1 of 1

2/17/2010 htt p s://rtairmail1.rt p .e p a. g ov/mail/mkin g .nsf/ ( $Sent ) /0A71D9BEFC9363DB852576CD007

...
COURT OF APPEALS FOR THE

FIRST DISTRICT OF TEXAS AT HOUSTON

ORDER

Cause No. 01-11-00545-CV; Lawrence S. Oleksy, Appellant v. Farmers Insurance Exchange, 

Appellee

On appeal from Trial Court Case No. 08-DCV-165626, in the 400th District Court of 

Fort Bend County, Texas.

This case was previously set for submission without oral argument on October 9, 2012. 

This case is hereby removed from the October 9, 2012 submission docket, and the Court requests 

that the parties provide supplemental briefing in accordance with this order. See TEX. R. APP. P.

38.7 (“A brief may be amended or supplemented whenever justice requires, on whatever 

reasonable terms the court may prescribe.”).

The Court requests briefing on the following issues:

1. The effect, if any, of N.Y. VEH. & TRAF. LAW § 2229 (“Snowmobile, not a motor 

vehicle”), and any other relevant related provision of the New York Vehicle and 

Traffic Law, on the parties’ arguments pertaining to construction and application 

in this case of the recreational vehicle exclusion to the motor-vehicle exception in 

the homeowner’s insurance policy at issue;

2. Whether the issues raised in the parties’ motions for summary judgment permit 

this Court to consider the effect, if any, of section 2229 of the New York Vehicle 

and Traffic Law on the construction of the homeowner’s insurance policy 

provisions at issue, see TEX. R. CIV. P. 166a(c); and

3. In light of the procedural posture of this summary-judgment appeal, what 

dispositions this Court may properly consider.

Olesky’s supplemental brief is due on October 22, 2012. Farmers Insurance Exchange’s 

supplemental brief is due November 5, 2012. Olesky’s reply brief, if any, is due November 19, 

2012. The Court requests that supplemental briefs be no longer than 10 pages and address only 

the issues identified in this order. 

It is so ORDERED.

Judge’s signature: /s/ Michael Massengale 

 Acting individually

Date: October 8, 2012
* Pursuant to Local Rule 47.5, the court has determined

that this opinion should not be published and is not precedent except under the limited circumstances set forth in Local Rule 47.5.4. IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 96-20409 Summary Calendar

UNITED STATES OF AMERICA, Plaintiff-Appellee,

versus BRIAN KEITH BABIN, Defendant-Appellant.

- - - - - - - - - - Appeal from the United States District Court for the Southern District of Texas USDC No. H-92-CR-156-1

- - - - - - - - - - March 28, 1997 Before JONES, DeMOSS, and PARKER, Circuit Judges. PER CURIAM: * Brian Keith Babin, #59963-079, appeals the district court’s summary denial of his motion to vacate, set aside or correct sentence pursuant to 28 U.S.C. § 2255. Babin’s claims that the court lacked jurisdiction over his drug-trafficking offenses because such offenses did not affect interstate commerce is without merit. United States v. Owens , 996 F.2d 59, 61 (5th Cir. 1993). His counsel was thus not ineffective in failing to challenge jurisdiction or in failing to request a special juryNo. 96-20409 - 2 - instruction regarding jurisdiction. Babin’s Double Jeopardy Clause argument fails both under Fifth Circuit precedent, United States v. Arreola-Ramos , 60 F.3d 188, 192 (5th Cir. 1995) and under the intervening case of United States v. Ursery , 116 S. Ct. 2135, 2147-49 (1996). AFFIRMED.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Deposit Insurance Corporation

*Notice is hereby given*                     that the Federal Deposit Insurance Corporation (“FDIC”) as Receiver for Premier American Bank, Miami, Florida (“the Receiver”) intends to terminate its receivership for said institution. The FDIC was appointed receiver of Premier American Bank on January 22, 2010. The liquidation of the receivership assets has been completed. To the extent permitted by available funds and in accordance with law, the Receiver will be making a final dividend payment to proven creditors.                

Based upon the foregoing, the Receiver has determined that the continued existence of the receivership will serve no useful purpose. Consequently, notice is given that the receivership shall be terminated, to be effective no sooner than thirty days after the date of this Notice. If any person wishes to comment concerning the termination of the receivership, such comment must be made in writing and sent within thirty days of the date of this Notice to: Federal Deposit Insurance Corporation, Division of Resolutions and Receiverships, Attention: Receivership Oversight Department 32.1, 1601 Bryan Street, Dallas, TX 75201.

No comments concerning the termination of this receivership will be considered which are not sent within this time frame.

Dated: April 13, 2015.

Federal Deposit Insurance Corporation.

Robert E. Feldman,

Executive Secretary.

[FR Doc. 2015-08790 Filed 4-16-15; 8:45 am]

 BILLING CODE 6714-01-P
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3830 Introduced in House (IH)]

111th CONGRESS
  1st Session
                                H. R. 3830

  To direct the Secretary of Health and Human Services to develop an 
 individual chronic disease prevention and wellness achievement matrix.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            October 15, 2009

 Mr. Fortenberry introduced the following bill; which was referred to 
                  the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
  To direct the Secretary of Health and Human Services to develop an 
 individual chronic disease prevention and wellness achievement matrix.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Health and Wellness for Americans 
Act of 2009''.

SEC. 2. INDIVIDUAL CHRONIC DISEASE PREVENTION AND WELLNESS ACHIEVEMENT 
              MATRIX.

    (a) Development.--The Secretary of Health and Human Services shall 
develop an individual chronic disease prevention and wellness 
achievement matrix--
            (1) to assist individuals to lower their risks of chronic 
        disease;
            (2) to achieve overall reductions in the incidence of 
        chronic disease on a national scale; and
            (3) to lay the foundation for future policies that 
        incentivize achievements based on the matrix.
    (b) Factors.--The matrix under subsection (a) shall consist of 
easily measurable, demonstrable, clinical factors as follows:
            (1) Achieving the recommended body mass index for an 
        individual's height and weight, or alternatively, an 
        individual's recommended waist circumference.
            (2) Achieving recommended lipid profile levels that make up 
        a full lipid panel, or alternatively the recommended ratio of 
        high density lipoprotein (HDL) to low density lipoprotein 
        (LDL).
            (3) Achieving the recommended blood pressure level.
            (4) Completing all cancer screenings for age and gender, 
        based on guidelines of the U.S. Preventive Services Task Force.
            (5) Achieving non-smoking status.
            (6) Achieving the recommended fasting blood sugar level 
        (or, if diabetic, the recommended hemoglobin A1c level).
                                 <all>
```
#### Allen Vance & Wife, et al. *v.*Charles F. Gary, Adm’r.

Where upon the sale of .the effects of an intestate, the administrator purchased property to the amount of three thousand four hundred dollars. Held, that in the adjustment of his accounts before the commissioner, he was entitled to commissions upon the same.

An administrator is entitled to commissions upon monies paid hy him in the administration of the estate, though paid after the bill for an account was filed and under the decree of the court.

*Before HARPER, Chancellor, at Laurens, June Term,*1838.

The bill in this case was filed by complainants, as the legal representatives of Martin Gary, against the defendant as his administrator, for an account of the estate of his intestate. At the sale by defendant, as administrator, he purchased property to the value of $3,400 — and the commissioner in adjusting the accounts, allowed defendant *2^*per cent, commissions for paying out the amount of his purchase, but refused to allow him commissions for receiving the same. The commissioner allowed commissions to defendant for money paid after bill filed and collected under a decree of this court.

To the commissioners report, exceptions were filed both by complainant and defendant, two only of which are necessary to be brought to the view of the court. To wit: By the complainant, “ Because the commissioner allowed the defendant commissions for money collected from him after bill filed and under *the decree of the court.*And by the defendant, “Because the commissioner did not allow defendant commissions on $3,400, for receiving the same, being the amount purchased by him at his own sale.

The presiding chancellor overruled complainants exception and sustained the defendant’s; and from this part of the decree, complainants appealed and moved to reverse the same upon the ground, *3that the chancellor should have sustained complainants exception, and overruled the exception of defendant.

*Young,*for complainants.

Per Curiam.

The court concur in the chancellor’s decree, and the same is affirmed.

David Johnson,

Benjamin F. Dunkin,

Job Johnston.
Exhibit 32.1

            CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
                 PURSUANT TO 18 U.S.C. SECTION 1350
                 AS ADOPTED PURSUANT TO SECTION 906
                 OF THE SARBANES-OXLEY  ACT OF 2002

     In connection with the Quarterly Report on Form 10-Q of Financial
Federal Corporation (the "Company") for the quarter ended January 31,
2006, as filed with the Securities and Exhange Commission (the
"Report"), Paul R. Sinsheimer, Chief Executive Officer of the
Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that to his knowledge:

     (1) the Report fully complies with the requirements of Section
     13(a) or 15(d) of the Securities Exchange Act of 1934; and

     (2) the information contained in the Report fairly presents, in
     all material respects, the financial condition and results of
     operations of the Company

     A signed original of this written statement required by section
906 has been provided to the Company and will be retained by the
Company and furnished to the Securities and Exchange Commission or its
staff upon request.



March 7, 2006                    /s/ Paul R. Sinsheimer
-------------                    ---------------------------
Date                             Paul R. Sinsheimer
                                 Chief Executive Officer and President